Renalytix plc Quarterly Cash and Cash Equivalents, Period Increase (Decrease) in USD for Q2 2018
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
-
Summary
-
Renalytix plc annual/quarterly Cash and Cash Equivalents, Period Increase (Decrease) history and growth rate for Q2 2018.
- Renalytix plc Cash and Cash Equivalents, Period Increase (Decrease) for the quarter ending June 30, 2018 was $82K.
- Renalytix plc annual Cash and Cash Equivalents, Period Increase (Decrease) for 2022 was -$23.8M, a 146% decline from 2021.
- Renalytix plc annual Cash and Cash Equivalents, Period Increase (Decrease) for 2021 was $51.8M, a 918% increase from 2020.
- Renalytix plc annual Cash and Cash Equivalents, Period Increase (Decrease) for 2020 was $5.09M, a 37.3% decline from 2019.
Cash and Cash Equivalents, Period Increase (Decrease), Quarterly (USD)